Search

Elizabeth A Mazzio

from Quincy, FL
Age ~62
Get Report
Also known as:
Elizabeth Anne Mazzio, Liz A Mazzio, Elizbeth Mazzio, Elizabeth A Maz, Elizabetha Mazzio, Elizabeth O
Phone and address:
182 Shrell Ln, Quincy, FL 32351
(850) 875-2252
Related to:
Albert L Boasberg, 88
Connected to:
Brittany Mazzio, 32Jade L Mazzio, 42Joann S Mazzitelli, 52Luigi N Mazzitelli, 59Lisa M Mazzo, 38Matthew R Mazzo, 44Adam Mazzocchetti, 46Eugene M Mazzocchi, 78Karen M Mazzocchio, 59Samantha J Mazzocchi, 59

Elizabeth Mazzio Phones & Addresses

  • 182 Shrell Ln, Quincy, FL 32351 (850) 875-2252
  • 982 Brevard St, Tallahassee, FL 32304 (850) 681-2143 (850) 681-2198
  • 982 W Brevard St APT D20, Tallahassee, FL 32304 (850) 681-2143
  • 982 W Brevard St, Tallahassee, FL 32304 (850) 380-9002

Work

Company: Florida a&m university Position: Research

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Florida State University 1992 to 1999 Specialities: Nutrition, Exercise Science

Skills

Science • Molecular Biology • Cell Culture • Biochemistry • Research • Hplc • Grant Writing • Teaching • Pharmacology • University Teaching • Higher Education • Theory • Drug Delivery • Curriculum Development • Lifesciences • Statistics • Western Blotting • Life Sciences • Chemistry • Pcr • Microscopy • Uv/Vis • Elisa • In Vitro • Protein Chemistry • Pharmacokinetics • Protein Purification • Cell Biology

Languages

English

Interests

Exercise • Reading • Sports • Health • Children • Cooking • Electronics • Outdoors • Education • Environment • Science and Technology • Camping • Human Rights • Civil Rights and Social Action • Poverty Alleviation • Automobiles • Career • Economic Empowerment • Animal Welfare

Industries

Pharmaceuticals

Resumes

Resumes

Elizabeth Mazzio Photo 1

Research

View page
Location:
182 Shrell Ln, Quincy, FL 32351
Industry:
Pharmaceuticals
Work:
Florida A&M University
Research
Education:
Florida State University 1992 - 1999
Doctorates, Doctor of Philosophy, Nutrition, Exercise Science Framingham State University 1987 - 1989
Master of Science, Masters, Nutrition, Food Science University of Massachusetts Amherst 1980 - 1984
Bachelors, Bachelor of Science, Chemistry, Food Science Needham High School 1977 - 1980
Skills:
Science
Molecular Biology
Cell Culture
Biochemistry
Research
Hplc
Grant Writing
Teaching
Pharmacology
University Teaching
Higher Education
Theory
Drug Delivery
Curriculum Development
Lifesciences
Statistics
Western Blotting
Life Sciences
Chemistry
Pcr
Microscopy
Uv/Vis
Elisa
In Vitro
Protein Chemistry
Pharmacokinetics
Protein Purification
Cell Biology
Interests:
Exercise
Reading
Sports
Health
Children
Cooking
Electronics
Outdoors
Education
Environment
Science and Technology
Camping
Human Rights
Civil Rights and Social Action
Poverty Alleviation
Automobiles
Career
Economic Empowerment
Animal Welfare
Languages:
English

Business Records

Name / Title
Company / Classification
Phones & Addresses
Elizabeth Mazzio
President
The Tallahassee Nutrition Company
Ret Misc Foods
982 W Brevard St, Tallahassee, FL 32304
182 Shrell Ln, Quincy, FL 32351
Elizabeth Mazzio
CEO
Capital Resource and Financial Inc
982 W Brevard St, Tallahassee, FL 32304

Publications

Us Patents

Method Of Treating Dyshidrosis(Pompholyx) And Related Dry Skin Disorders

View page
US Patent:
7666451, Feb 23, 2010
Filed:
Jan 11, 2008
Appl. No.:
12/008719
Inventors:
Elizabeth Anne Mazzio - Tallahassee FL, US
Karam F Soliman - Tallahassee FL, US
International Classification:
A01N 65/00
US Classification:
424725, 424771, 424730, 424740, 424754, 424757, 424729, 424748, 424744, 424539, 514861
Abstract:
A method of use for a topical herbal formulation alone or in combination with oral administration of niacin (preferably a flush preparation) to prevent and/or treat dyshidrosis (pompholyx) and related skin diseases. The formulation may also be used to treat contact dermatitis, eczema, palmoplantar pustulosis and skin infections incurred by invasive pathogens such as mold, fungus and bacteria. The formulation is comprised of plant extracts and niacin, that when combined yield an effective multi-faceted pharmaceutical approach to treating dry skin disorders. The active ingredients within the formula include a combination of dry, aqueous, acid and alcohol extracts of black walnut hull (), wormwood (), tumeric rhizome (), garlic (), two or more herbal antibacterial agents from the group consisting of chamomile (), licorice root (), St Johns wort (), clove (), nutmeg (), ginger (), frankincense () and myrrh (), further combined with aloe vera and niacin.

Nutraceutical Agent For Attenuating The Neurodegenerative Process Associated With Parkinson's Disease

View page
US Patent:
8367121, Feb 5, 2013
Filed:
Feb 6, 2010
Appl. No.:
12/658307
Inventors:
Elizabeth Anne Mazzio - Tallahassee FL, US
Karam F Soliman - Tallahassee FL, US
Assignee:
Florida A & M University - Tallahassee FL
International Classification:
A61K 36/45
A61K 36/53
A61K 36/73
US Classification:
424641, 424732, 424736, 424730, 424757, 424765, 514505, 562562
Abstract:
This invention describes a comprehensive nutraceutical designed to antagonize major mitigating factors to the degenerative process associated with Parkinson's disease. The formulation is comprised of a primary base of pyruvate, succinate, α-Ketoglutarate and/or oxaloacetate, niacin/NADH, fruit extracts, anthocyanins, further combined with specific macro/micronutrients, trace elements, amino acids, flavonoids and concentrated plant sources. The nutraceutical contains all natural substances that should mitigate many of the neurodegenerative processes known to be associated with PD. Mechanisms addressed are to prevent the loss of ATP/by 1-methyl-4-phenylpyridinium rotenone, scavenge hydrogen peroxide/O. , augment antioxidant enzymes, prevent dopamine (DA) oxidation to DA-quinone via inhibition of COX, PLA, LOX, xanthine oxidase, tyrosinase, prevent hyperhomocysteinemia, antagonize PARP-1 apoptosis, increase blood flow, glucose and oxygen delivery to the brain, potentiate mitochondrial function, antagonize glia iNOS and MAO or its products, chelate redox-active iron, inhibit heme oxygenase-1, inhibit alpha-synuclein aggregation, augment ATP storage, mediate anti-inflammatory effects via inhibition of PDE, MAPK p38/c-Jun NH2-terminal kinase/PGE2, antagonize excitotoxicity and downregulate N-methyltransferase, all of which contribute toward PD pathology.

Topical Treatment For Dyshidrosis (Pompholyx) And Dry Skin Disorders

View page
US Patent:
20040185123, Sep 23, 2004
Filed:
Mar 16, 2004
Appl. No.:
10/801520
Inventors:
Elizabeth Mazzio - Tallahassee FL, US
Karam Soliman - Tallahassee FL, US
International Classification:
A61K035/78
US Classification:
424/730000, 424/740000, 424/771000, 424/757000, 424/764000, 424/744000
Abstract:
This invention discloses a topical herbal formulation for preventing and/or treating dyshidrosis (pompholyx), non-responsive to topical steroids. The formulation may also be used to treat contact dermatitis, eczema, palmoplantar pustulosis and skin infections incurred by invasive pathogens such as mold, fungus and bacteria. The formulation is comprised of plant extracts and niacin, that when combined yield an effective multi-faceted pharmaceutical approach to treating dry skin disorders. The active ingredients within the formula include a combination of dry, aqueous, acid and alcohol extracts of black walnut hull (), wormwood (), tumeric rhizome (), garlic (), chamomile (), licorice root (), St Johns wort (), aloe vera, niacin and herbal anti-bacterial agents.

Inhibition Of Anaerobic Glucose Metabolism And Corresponding Composition As A Natural Non-Toxic Approach To Cancer Treatment

View page
US Patent:
20060035981, Feb 16, 2006
Filed:
Sep 20, 2005
Appl. No.:
11/233279
Inventors:
Elizabeth Mazzio - Tallahassee FL, US
Karam Soliman - Tallahassee FL, US
International Classification:
A61K 31/12
A61K 31/7072
A61K 31/7076
A61K 31/525
A61K 36/328
A61K 36/23
A61K 36/906
US Classification:
514690000, 514045000, 514051000, 514027000, 514251000, 424725000, 424748000, 424756000, 424745000, 424746000, 424729000
Abstract:
This invention discloses a method and formulation for treatment/prevention of human and animal cancers. The invention is designed to exploit the vulnerability of cancer with regards to its anaerobic requirement for non-oxidative phosphorylation of glucose to derive energy, which is opposite to the host. The composition is comprised of a combination of one or more of (A) 2,3-dimethoxy-5-methyl-1,4-benzoquinone, ubiquinones (5-45) (B) compound(s) capable of augmenting oxidative phosphorylation such as a riboflavin containing compound and/or ubiquinone (50) (C) 2′,3,4′5,7-pentahydroxyflavone or a lactic acid dehydrogenase inhibitor and (D) compounds (s) that antagonize gluconeogenesis from non-glucose carbon based substrates. The combination of these substances should favor oxidative loss of carbon through decarboxylation reactions, suppress gluconeogenesis and initiate collapse of glycolysis in tumor tissue, a chemical manipulation that should be non-toxic or perhaps even beneficial to normal respiring host tissue. Pilot studies indicate the treatment to be effective without side effects.

Comprehensive Nutraceutical Agent For Treatment/ Prevention Of Parkinson's Disease

View page
US Patent:
20070116779, May 24, 2007
Filed:
May 22, 2006
Appl. No.:
11/438746
Inventors:
Elizabeth Mazzio - Tallahassee FL, US
International Classification:
A61K 35/64
A61K 33/42
A61K 36/82
A61K 36/736
A61K 36/539
A61K 36/53
A61K 36/534
A61K 36/899
A61K 36/16
A61K 36/73
A61K 36/87
A61K 36/48
A61K 36/28
A61K 36/42
US Classification:
424539000, 424602000, 424725000, 424729000, 424747000, 424741000, 424764000, 424765000, 424745000, 424735000, 424757000, 424766000, 424750000, 424758000, 424752000, 514018000, 514562000, 514554000
Abstract:
This invention discloses a comprehensive nutraceutical designed to antagonize major mitigating factors specific to the degenerative process that occurs in Parkinson's disease (PD). The formulation is comprised of pyruvate, succinate and/or oxaloacetate further combined with specific macro/micronutrients, trace elements, amino acids, flavonoids and concentrated plant sources. The formula is based on means to attenuate the loss of ATP/toxicity by PD model toxins: 1-methyl-4-phenylpyridinium and rotenone, scavenge hydrogen peroxide/O, augment antioxidant enzymes, prevent dopamine oxidation to DA-quinone via inhibition of COX, PLA, LOX, xanthine oxidase, tyrosinase, prevent hyperhomocysteinemia, antagonize PARP-1 apoptosis, increase blood flow, glucose and oxygen delivery to the brain, potentiate mitochondrial function, antagonize glia iNOS and MAO or its products, chelate redox-active iron, inhibit hemeoxygenase-1, inhibit alpha-synuclein aggregation, augment ATP storage, mediate anti-inflammatory effects via inhibition. of PDE, MAPK p38/c-Jun NH2-terminal kinase/PGE2, antagonize excitotoxicity and downregulate N-methyltransferase, all of which contribute toward PD pathology.

Nutraceutical Composition And Method Of Use For Treatment / Prevention Of Cancer

View page
US Patent:
20070248693, Oct 25, 2007
Filed:
Feb 27, 2007
Appl. No.:
11/711883
Inventors:
Elizabeth Mazzio - Tallahassee FL, US
Karam Soliman - Tallahassee FL, US
International Classification:
A61K 36/00
A61P 35/00
US Classification:
424725000
Abstract:
The invention describes a pharmaceutical composition and method for treating cancer comprised of A) 2,3-dimethoxy-5-methyl-1,4-benzoquinone and/or B) at least one of wild yam root, teasel root, balm of gilead bud, bakuchi seed, root, seed, kanta kari, bushy knotweed rhizome, arjun, babul chall bark, and bhumy amalaki; optionally one or more of frankincense, fruit, , dragons blood, mace, sage and red sandalwood with at least c) one compound capable of maximizing oxidative mitochondrial function preferably riboflavin or vitamin Bderivatives, FAD, FMN, 5-amino-6-(5′-phosphoribitylamino)uracil, 6,7-Dimethyl-8-(1-D-ribityl)lumazine, ribitol, 5,6-dimethylbenzimidazole, tetrahydrobiopterin, vitamin B, lipoic acid, biotin, vitamin B, vitamin B, folate, niacin, vitamin C and pantothenate and/or d) at least one lactic acid dehydrogenase inhibitor (preferably 2′,3,4′5,7-pentahydroxyflavone) and optionally f) an alkalizing agent (, wheat grass, sodium or potassium bicarbonate, potassium) g) an antiproliferative herb (or goldenseal) and h) a pharmaceutically acceptable carrier.

Nutraceutical Agent For Attenuating The Neurodegenerative Process Associated With Parkinson's Disease

View page
US Patent:
20080292607, Nov 27, 2008
Filed:
Jul 29, 2008
Appl. No.:
12/220810
Inventors:
Elizabeth Mazzio - Tallahassee FL, US
Karam Soliman - Tallahassee FL, US
International Classification:
A61K 36/00
A61K 36/45
A61K 36/736
A61K 36/752
A61K 33/30
A61P 25/16
A61K 36/73
A61K 36/82
A61K 36/48
US Classification:
424 941, 424732, 424735, 424736, 424765, 424729, 424757, 424641
Abstract:
This invention describes a comprehensive nutraceutical designed to antagonize major mitigating factors to the degenerative process associated with Parkinson's disease. The formulation is comprised of a primary base of pyruvate, succinate and/or oxaloacetate, fruit extracts and anthocyanins, further combined with specific macro/micronutrients, trace elements, amino acids, flavonoids and concentrated plant sources. The nutraceutical contains substances that should attenuate the loss of ATP/toxicity by PD model toxins: 1-methyl-4-phenylpyridinium and rotenone, scavenge hydrogen peroxide/O., augment antioxidant enzymes, prevent dopamine (DA) oxidation to DA-quinone via inhibition of COX, PLA, LOX, xanthine oxidase, tyrosinase, prevent hyperhomocysteinemia, antagonize PARP-1 apoptosis, increase blood flow, glucose and oxygen delivery to the brain, potentiate mitochondrial function, antagonize glia iNOS and MAO or its products, chelate redox-active iron, inhibit heme oxygenase-1, inhibit alpha-synuclein aggregation, augment ATP storage, mediate anti-inflammatory effects via inhibition of PDE, MAPK p38/c-Jun NH2-terminal kinase/PGE2, antagonize excitotoxicity and downregulate N-methyltransferase, all of which contribute toward PD pathology.

Nutraceutical Composition And Method Of Use For Treatment / Prevention Of Cancer

View page
US Patent:
20100209388, Aug 19, 2010
Filed:
Jan 30, 2010
Appl. No.:
12/657903
Inventors:
Elizabeth Anne Mazzio - Tallahassee FL, US
Karam F. Soliman - Tallahassee FL, US
International Classification:
A61K 38/21
A61P 35/00
A61P 35/02
A61K 36/53
A61K 36/324
A61K 36/52
A61K 36/484
A61K 36/54
A61K 36/9068
A61K 36/82
A61K 36/8945
A61K 36/537
A61K 36/886
A61K 36/05
A61K 36/899
A61K 36/73
A61K 36/71
A61K 38/50
A61K 33/24
US Classification:
424 854, 424745, 424769, 424771, 424757, 424739, 424756, 424729, 424725, 424746, 424744, 42419517, 424750, 424765, 424726, 424 946, 424649
Abstract:
The invention describes a nutraceutical composition and method for preventing/treating cancer comprised of A) quinones (2,3-dimethoxy-5-methyl-1,4-benzoquinone, thymoquinone, tocopherolquinone) B) compounds capable of maximizing oxidative mitochondrial function preferably riboflavin, FAD, FMN, 6,7-Dimethyl-8-(1-D-ribityl)lumazine, ribitol, 5,6-dimethylbenzimidazole, tetrahydrobiopterin, vitamin B, lipoic acid, biotin, vitamin B, vitamin B, folate, B3, C and pantothenate C) lactic acid dehydrogenase inhibitors; 2′,3,4′5,7-pentahydroxyflavone, epigallocatechin gallate, quercetin, citric acid, rosemary, black walnut, clove, nutmeg, licorice root, coriander, cinnamon, ginger root, myrrh gum and green tea D) alkalizing agents: , wheat grass, apple cider vinegar, burdock root, kudzu root, alfalfa, barley grass, spirulina, parsley leaf, calcium, magnesium, potassium or bicarbonate salts E) potent tumoricidal herbs; gromwell root, wild yam, beth root, teasel root, balm of gilead bud, frankincense, bakuchi seed, dichroa root, kochia seed, kanta kari, sweet myrrh, galbanum, fruit, mace, white sage and tumoricial plant derived constituents: gambogic acid, shikonin, diosmin or boswellic acid F) an antiproliferative herb (speranskia or goldenseal) and G) a pharmaceutically acceptable carrier.
Control profile
Elizabeth A Mazzio from Quincy, FL, age ~62 Get Report